CARLSBAD, Calif. (AP) _ Lineage Cell Therapeutics, Inc. (LCTX) on Thursday reported a fourth-quarter loss of $29 million, after reporting a profit in the same period a year earlier.The Carlsbad, California-based company said it had a loss of 17 cents per share. Losses, adjusted for non-recurring costs, came to 5 cents per share.The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 4 cents per share.The biotechnology company posted revenue of $1.2 million in the period, matching Street forecasts._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LCTX at https://www.zacks.com/ap/LCTX